Language: BG BG
nav.cta
← Back to results
Not yet recruiting Phase 4 NCT07474870

Outcomes of CTAK Surgery

Phase 4 – monitoring after market approval
Conditions: Keratoconus Corneal Ectasia

Sponsor: Stanford University

trial.available_in: БГ
Overview
Measuring quality of vision and quality of life outcomes using a validated questionnaire in participants undergoing CTAK surgery for corneal ectasia
Description
The investigators are measuring self-reported quality of vision and quality of life outcomes in participants undergoing CTAK surgery for corneal ectasia
Who can participate
Inclusion Criteria: * Corneal Ectasia and Keratoconus Exclusion Criteria: * Excessively thin cornea * Significant corneal scarring
Interventions
Questionnaire and Physical Exam
BEHAVIORAL
Locations 1
United States (1)
Byers Eye Institute at Stanford
Palo Alto , California
Edward Manche, MD
Technical details
Status
Not yet recruiting
Phase
Phase 4
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Maximum age
85 Years
Healthy volunteers
No
Start date
01.05.2026
Completion date
01.01.2031
Registry ID
NCT07474870
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.